We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Reduction of Remifentanil-related Complications by Limiting Maximum Plasma Concentration During Target-controlled Infusion

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01003028
Recruitment Status : Unknown
Verified May 2015 by Chul-Woo Jung, Seoul National University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : October 28, 2009
Last Update Posted : May 28, 2015
Information provided by (Responsible Party):
Chul-Woo Jung, Seoul National University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : December 2015